共 50 条
- [1] A randomized, double-blind, placebo-controlled trial of a probiotic preparation, Vsl#3, for the treatment of mild to moderate active ulcerative colitisGASTROENTEROLOGY, 2008, 134 (04) : A99 - A99Makharia, Govind K.Sood, AjitMidha, VandanaAhuja, VineetSingal, Dinesh K.Arora, ReenuSeed, ShamanGoswami, PoojaDe Simone, ClaudioSaha, Aditya R.Tandon, Rakesh K.
- [2] Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (10): : 2218 - 2227Tursi, AntonioBrandimarte, GiovanniPapa, AlfredoGiglio, AndreaElisei, WalterGiorgetti, Gian MarcoForti, GiacomoMorini, SergioHassan, CesarePistoia, Maria AntoniettaModeo, Maria EsterRodino', StefanoD'Amico, TeresaSebkova, LadislavaSacca', NataleDi Giulio, EmilioLuzza, FrancescoImeneo, MariaLarussa, TizianaDi Rosa, SalvatoreAnnese, VitoDanese, SilvioGasbarrini, Antonio
- [3] Effect of a probiotic preparation (VSL#3) in critically ill patients: A randomized, double-blind, placebo-controlled trial (Pilot Study)PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (02) : 490 - 494Ebrahimi-Mameghani, MehrangizSanaie, SarvinMahmoodpoor, AtaHamishehkar, Hadi
- [4] Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trialJOURNAL OF HOSPITAL INFECTION, 2013, 84 (02) : 159 - 165Selinger, C. P.Bell, A.Cairns, A.Lockett, M.Sebastian, S.Haslam, N.
- [5] Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled studyCLINICAL NUTRITION ESPEN, 2022, 51 : 83 - 91Agraib, Lana M.Yamani, Mohammed I.Tayyem, ReemaAbu-Sneineh, Awni TalebRayyan, Yaser Mohammed
- [6] Does probiotic supplementation improve quality of life in mild-to-moderately active ulcerative colitis patients in Jordan? A secondary outcome of the randomized, double-blind, placebo-controlled studyEUROPEAN JOURNAL OF NUTRITION, 2023, 62 (07) : 3069 - 3077Rayyan, Yaser MohammedAgraib, Lana M.Alkhatib, ButhainaYamani, Mohammed I.Abu-Sneineh, Awni TalebTayyem, Reema F.
- [7] The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trialEuropean Journal of Nutrition, 2023, 62 : 3125 - 3134Maryam KhazdouzNaser Ebrahimi DaryaniMakan CheraghpourForoogh AlborziMotahareh HasaniShaghayegh Baradaran GhavamiFarzad Shidfar
- [8] Does probiotic supplementation improve quality of life in mild-to-moderately active ulcerative colitis patients in Jordan? A secondary outcome of the randomized, double-blind, placebo-controlled studyEuropean Journal of Nutrition, 2023, 62 : 3069 - 3077Yaser Mohammed RayyanLana M. AgraibButhaina AlkhatibMohammed I. YamaniAwni Taleb Abu-SneinehReema F. Tayyem
- [9] The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trialEUROPEAN JOURNAL OF NUTRITION, 2023, 62 (08) : 3125 - 3134Khazdouz, MaryamDaryani, Naser EbrahimiCheraghpour, MakanAlborzi, ForooghHasani, MotaharehGhavami, Shaghayegh BaradaranShidfar, Farzad
- [10] Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trialBMC Complementary Medicine and Therapies, 24Sajjad MoradiReza BagheriParsa AmirianMahsa ZarpooshNeda CheraghlooAlexei WongMehdi ZobeiriMohammad Hassan Entezari